# Progress Note 01 — Initial plan

> **SYNTHETIC RECORD, NOT A REAL MEDICAL RECORD**

- Patient: Howard Hughes (real historical name used in a fictional teaching record)
- Synthetic MRN: HR-ML006-SYN
- Date: 2026-05-04
- Fictional facility: St. Posthumous Health Center
- Fictional author: Anselm Garrity-Moyo, MD
- Calendar frame: modern shifted

## Subjective

The patient participates in this fictional visit for establishing primary care ten months after a plane crash: contamination fears with washing and avoidance, chronic pain on long-term codeine, an opioid review, hearing, weight, kidney health and safety. **S**

## Objective

White blood cells: 6.4 10*3/uL; Hemoglobin: 14.1 g/dL; MCV: 91 fL; Platelets: 248 10*3/uL; Sodium: 139 mmol/L; Potassium: 4.2 mmol/L; Creatinine: 0.94 mg/dL; eGFR (CKD-EPI 2021): 104 mL/min/1.73 m²; Glucose: 84 mg/dL; AST: 31 U/L; ALT: 38 U/L; Albumin: 3.7 g/dL; TSH: 1.6 mIU/L; Urine albumin-to-creatinine ratio: 8 mg/g{creat}; PHQ-9: 9; GAD-7: 12; DAST-10: 5; AUDIT-C: 1; PEG pain scale: 6.7. All results are synthetic.

BP 122/78 mmHg; pulse 92 bpm; respirations 16/min; temperature 36.7 °C; oxygen saturation 98% on room air; weight 72 kg; BMI 19.7 kg/m². All vital signs are synthetic.

## Assessment

Active problems: Intrusive fears of contamination by germs for about a year, worse since the crash, with hand washing, cleaning of objects and avoidance of handshakes, shared spaces and food handled by others, taking about four hours a day; he recognizes the fears are probably excessive; cause under evaluation; Opioid use disorder, moderate (four of the DSM-5-TR criteria that count for a prescribed opioid: taking more than prescribed, failed attempts to cut down, time spent getting prescriptions from two prescribers, and craving), on codeine prescribed after a crash; buprenorphine planned; Chronic pain after major trauma ten months ago (crushed chest with rib fractures, collapsed lung, other fractures and burns): chest wall, left shoulder and low back pain, PEG 6.7; Difficulty hearing conversation, worse in noise, after years of flying in loud aircraft; cause under evaluation; Weight loss of about 8 kg since the crash (BMI 19.7), from eating little outside food he has prepared or inspected himself because of contamination fears. Strengths and supports remain part of the care plan. **S**

## Medication changes

- Started: Acetaminophen 300 mg with codeine 30 mg oral tablet, prescribed elsewhere since the crash as one or two tablets every 6 hours as needed, no more than 8 a day; he has been taking 10 to 12 a day **S**
- Started: Naloxone 4 mg nasal spray, one spray into one nostril for a suspected opioid overdose, repeated every two to three minutes in the other nostril if needed; two-pack dispensed, with instruction for him and his household staff **S**

## Plan

- Psychiatry consultation to confirm the diagnosis, advise on an SSRI at OCD doses with buprenorphine, plan exposure and response prevention, and advise on how his staff can stop carrying out rituals for him. Guideline: Practice Guideline for the Treatment of Patients With Obsessive-Compulsive Disorder (2007); Guideline Watch (March 2013): Practice Guideline for the Treatment of Patients With Obsessive-Compulsive Disorder (Koran LM, Simpson HB), as reported by Psychiatric News (2013); Obsessive-compulsive disorder and body dysmorphic disorder: treatment (CG31) (2005) **S**
- Opioid review under the CDC 2022 guideline: benefits and harms reviewed with him, a prescription drug monitoring program check before every controlled-substance prescription, urine drug testing with consent and explained as part of care, one prescriber and one pharmacy, a nonjudgmental DSM-5-TR assessment for opioid use disorder, and no abrupt stop of codeine. Guideline: CDC Clinical Practice Guideline for Prescribing Opioids for Pain - United States, 2022 (2022); Prescription Drug Monitoring Programs (PDMPs) (2026) **S**
- Buprenorphine with naloxone for opioid use disorder and pain: induction in the clinic at one week after about 20 hours without codeine, then 8 mg twice daily, dispensed weekly at first; naloxone nasal spray at home; no benzodiazepines; leftover codeine to a pharmacy take-back. Guideline: CDC Clinical Practice Guideline for Prescribing Opioids for Pain - United States, 2022 (2022); The ASAM National Practice Guideline for the Treatment of Opioid Use Disorder: 2020 Focused Update (2020) **S**
- Pain after major trauma: scheduled acetaminophen up to 3,000 mg a day, physical therapy for the chest wall, left shoulder and low back, graded activity, sleep, and pain coping skills woven into his therapy; no NSAID long term. Guideline: CDC Clinical Practice Guideline for Prescribing Opioids for Pain - United States, 2022 (2022) **S**
- Safety: a structured safety assessment, a written safety plan, the 988 Suicide & Crisis Lifeline in his phone, means safety for opioids, and safety review at every visit. Guideline: VA/DoD Clinical Practice Guideline for Assessment and Management of Patients at Risk for Suicide (2024); CMID: Clinical Monitoring Intelligence Database, depression, bipolar, and mood disorders monograph (2026) **S**
- Hearing: audiometry, then hearing aids and a remote microphone if hearing loss is confirmed; hearing protection when flying and in the factory. Guideline: Hearing loss in adults: assessment and management (NG98) (2018) **S**
- Kidney health: creatinine, eGFR and urine albumin at baseline and a metabolic panel at follow-up while on scheduled acetaminophen and any new medicine; acetaminophen kept at or below 3,000 mg a day; no long-term NSAID. Guideline: CDC Clinical Practice Guideline for Prescribing Opioids for Pain - United States, 2022 (2022) **S**
- Privacy: care documented in the clinic record only; letters about his health go only to people he names. Guideline: Practice Guideline for the Treatment of Patients With Obsessive-Compulsive Disorder (2007) **S**
